Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inmune Bio Inc
(NQ:
INMB
)
7.130
+0.260 (+3.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Inmune Bio Inc
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 20, 2024
Via
Benzinga
INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023
March 28, 2024
INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
INmune Bio: Q4 Earnings Insights
March 28, 2024
Via
Benzinga
A Preview Of INmune Bio's Earnings
March 27, 2024
Via
Benzinga
Why Is Elevai Labs (ELAB) Stock Up Today?
January 16, 2024
Elevai Labs is soaring on an intriguing licensing agreement with INmune Bio, but the narrative presents a mixed bag for ELAB stock.
Via
InvestorPlace
Earnings Outlook For INmune Bio
August 04, 2023
Via
Benzinga
INmune Bio's Earnings Outlook
May 02, 2023
Via
Benzinga
INmune Bio Earnings Perspective: Return On Capital Employed
March 08, 2023
Via
Benzinga
Earnings Preview: INmune Bio
March 01, 2023
Via
Benzinga
INmune Bio's INKmune Shows Positive Efficacy In Multiple Cancer Cell Lines
October 19, 2022
Via
Benzinga
Earnings Scheduled For March 28, 2024
March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
Why Elevai Labs Stock Is Trading Higher
January 16, 2024
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 19, 2023
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning!
Via
InvestorPlace
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease.
Via
Investor's Business Daily
INmune Bio – Helping Your Own Cells Fight Cancer And Reverse Alzheimer's Disease
June 13, 2023
David Moss, CEO of INmune Bio (NASDAQ: INMB) was recently a guest on Benzinga’s All-Access.
Via
Benzinga
The 7 Best Biotech Stocks for Personalized Medicine Investors
April 25, 2023
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023
June 01, 2023
Via
Benzinga
Dow Jumps 250 Points; US Jobless Claims Increase Last Week
February 09, 2023
U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose,...
Via
Benzinga
Nasdaq Tumbles 150 Points; Crude Oil Up 1.5%
February 08, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 150 points on Wednesday. The Dow traded down 0.27% to 34,063.42 while the NASDAQ fell 1.33% to 11,952.51. The...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 25, 2023
Via
Benzinga
Recap: INmune Bio Q2 Earnings
August 03, 2022
INmune Bio (NASDAQ:INMB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings INmune Bio beat estimated...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 24, 2022
Via
Benzinga
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
May 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
71 Biggest Movers From Yesterday
May 25, 2022
Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
May 24, 2022
Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.
Via
Benzinga
A Preview Of INmune Bio's Earnings
May 04, 2022
INmune Bio (NASDAQ:INMB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that INmune Bio will...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
May 24, 2022
Upgrades
Via
Benzinga
60 Biggest Movers From Yesterday
April 26, 2022
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.